A. Coxskun et al. / Tetrahedron 63 (2007) 4944–4950
4949
endoperoxide 28 was completely converted into the furanoid
3.11. Photooxygenation of 4-(acetyloxy)-5-oxocyclo-
hepta-1,3,6-trien-1-yl acetate (34b)
31. A flash chromatography on silica gel allowed to
isolate the furanoid 31 in 83% yield as a pale yellow wax,
513 mg.
The reaction was carried out according to the above-men-
tioned procedure (Section 3.9) by using 2.0 g (9.0 mmol)
of 34b and TPP (10 mg, 0.016) in 200 mL of CCl4. After
2-(Acetyloxy)ethyl(2Z)-3-[2-(acetyloxy)-5-oxo-2,5-dihydro-
furan-2-yl]prop-2-enoate (31): 1H NMR (400 MHz,
1
4-day irradiation, the solvent was evaporated and the H
0
0
CDCI3): 7.80 (d, A part of AB system, J3 ,4 ¼5.5 Hz,
NMR analysis of residue indicated the formation of the
endoperoxide 35 (41%) and furan derivative 36 (44%). The
crude mixture was chromatographed on silica gel (20 g)
eluting with n-hexane/ethyl acetate (5:1). The first fraction
was identified as endoperoxide 35 (isolated yield 88 mg,
4%, pale green wax).
1H, H3), 6.38 (d, A part of AB system, J2,3¼12.4 Hz,
0
0
1H, H3), 6.21 (d, B part of AB system, J3 ,4 ¼5.5 Hz, 1H,
0
H4 ), 6.15 (d, B part of AB system J2,3¼12.4 Hz, 1H, H2),
4.34–4.30 (m, A2 part of A2B2 system OCH2), 4.29–4.25
(m, B2 part of A2B2 system OCH2), 2.06 (s, 3H, CH3),
2.05 (s, 3H, CH3). 13C NMR (100 MHz, CDCI3): 170.90,
169.32, 168.08, 164.38, 151.55, 139.38, 123.85, 123.28,
103.58, 63.08, 62.01, 21.04, 20.98. IR (NaCl film): 3113,
3061, 2962, 1790, 1733, 1440, 1392, 1373, 1228, 1195,
1079, 1016, 915, 820. MS (EI, 70 eV) m/z 195
(M+ꢂAcOH–CO2, 2), 168 (4), 153 (4), 137 (6), 125 (5),
109 (5), 88 (100), 83 (20), 71 (10), 54 (24). Anal.
Calcd for C13H14O8: C, 52.35; H, 4.73. Found: C, 52.60;
H, 5.09.
5-(Acetyloxy)-2-oxo-6,7-dioxabicyclo-[3.2.2]nona-3,8-dien-
1-yl acetate (35): H NMR (400 MHz, CDCI3): 6.84 (d,
1
J3,4¼8.4, 1H, H4), 6.12 (dd, J8,9¼8.8, J3,9¼1.8, 1H, H9),
5.25 (dd, J8,9¼8.8, J3,8¼0.7, 1H, H8), 5.20 (ddd, J3,4¼8.4,
J3,9¼1.8, J3,8¼0.7, 1H, H3), 2.23 (s, 3H, CH3), 2.22 (s, 3H,
CH3). 13C NMR (100 MHz, CDCI3): 188.32, 168.42, 168.26,
157.68, 146.45, 129.70, 103.25, 83.13, 76.65, 21.00, 20.49.
IR (NaCl film): 3093, 2926, 1766, 1706, 1372, 1199, 1171,
1117, 1017, 923, 830. Anal. Calcd for C11H10O7: C, 51.98;
H, 3.97. Found: C, 51.24; H, 4.09.
3.10. Acetylation of 2,5-dihydroxycyclohepta-2,4,6-
trien-1-one (33)
The furan derivative could not be isolated from column, but
spectral analyses were performed on the crude products.
The reaction was carried out according to the above-
mentioned procedure (Section 3.3) by using 2.0 g
(14.5 mmol) of 33, pyridine (12 ml), and acetic anhydride
(5.5 mL). After 16 h, the solvent and excess acetic anhydride
Acetic (2Z)-3-[2-(acetyloxy)-5-oxo-2,5-dihydrofuran-2-yl]-
prop-2-enoic anhydride (36): 1H NMR (400 MHz,
1
0
0
0
were evaporated and H NMR analysis of the residue indi-
CDCI3): 7.70 (d, J3 ,4 ¼5.5, 1H, H3 ), 6.31 (d, A part of
cated the formation of the diacetate 34b15 and monoacetate
34a.17 The residue was chromatographed on a silica gel
(30 g) column eluting with n-hexane/ethyl acetate (95:5).
The first fraction was identified as 34a17 (321 mg, 12%,
brown crystals from methylene chloride/n-hexane 1:4, mp
109–110 ꢀC, lit.17 mp 107–108 ꢀC).
AB system, J2,3¼12.5, 1H, H3), 6.17 (d, J3 ,4 ¼5.5, 1H,
0 0
0
H4 ), 5.99 (d, B part of AB system, J2,3¼12.5, 1H, H2),
2.02 (s, 3H, CH3), 2.00 (s, 3H, CH3). 13C NMR (50 MHz,
CDCI3): 169.95, 168.80, 168.73, 151.83, 146.19, 138.98,
124.26, 123.23, 103.71, 20.92, 20.40.
3.12. Oxidation of 14 with m-chloroperbenzoic acid
4-Hydroxy-5-oxocyclohepta-1,3,6-trien-1-yl acetate (34a):
1H NMR (400 MHz, CDCl3): 8.57 (m, 1H, OH), 7.22 (AA0
part of AA0BB0 system, 2H, H3, H6 or H2, H7), 7.10 (BB0
part of AA0BB0 system, 2H, H3, H6 or H2, H7), 2.26 (s,
3H, CH3). 13C NMR (100 MHz, CDCl3): 172.76, 171.37,
151.29, 133.64, 124.57, 22.84. IR (NaCl film): 3218, 1750,
1563, 1463, 1420, 1268, 1200, 1149, 853, 758. MS (EI,
70 eV) m/z 180 (M+, 3), 168 (6), 139 (100), 131 (9), 111
(63), 91 (38), 75 (30), 65 (17), 55 (22).
The reaction was carried out according to the above-men-
tioned procedure (Section 3.2) by using 0.85 g (4.67 mmol)
of 14 and m-CPBA (0.97 g, 5.60) in 25 mL of CH2Cl2. The
solvent was removed. The crude was extracted with Et2O
(3ꢁ30 mL) and the combined ethereal extracts were dried
over MgSO4 and concentrated in vacuo. The residue was pu-
rified from silica gel (20 g) using n-hexane/ethyl acetate 6:4
(white crystals from CH2Cl2/n-hexane (1:3), 370 mg 40%,
mp 138–139 ꢀC).
The second fraction was identified as 34b15 (2.32 g, 72%,
brown crystals from methylene chloride/n-hexane 1:4, mp
97–98 ꢀC, lit.15 mp 93–95 ꢀC).
Spiro[1-hydroxy-7,9-dioxatricyclo[3.3.1.06,8]nona-3-ene-
1
2,20-[1,3]dioxolane] (38): H NMR (400 MHz, CDCI3):
6.29 (dd, A part of AB system, J3,4¼9.5, J4,5¼4.0, 1H, H4),
5.67 (d, B part of AB system, J3,4¼9.5, 1H, H3), 4.50 (d,
J4,5¼4.0, 1H, H5), 4.21–4.04 (m, 4H, OCH2), 3.96 (m,
1H, OH), 3.73 (d, A part of AB system, J6,8¼3.1, 1H, H8),
3.66 (d, B part of AB system, J6,8¼3.1, 1H, H6). 13C NMR
(50 MHz, CDCI3): 135.11, 132.35, 104.64, 102.53, 74.34,
68.57, 68.15, 59.09, 53.49. IR (NaCl film): 3399, 2983,
2900, 1474, 1373, 1291, 1195, 1167, 1027, 954, 875,
793. MS (EI, 70 eV) m/z 198 (M+, 0.2), 169 (8), 153
(28), 141 (4), 125 (11), 109 (24), 97 (17), 86 (31), 81
(100), 68 (55). Anal. Calcd for C9H10O5: C, 54.55; H,
5.09. Found: C, 53.65; H, 4.84.
4-(Acetyloxy)-5-oxocyclohepta-1,3,6-trien-1-yl acetate (34b):
1H NMR (200 MHz, CDCl3): 7.15 (d, A part of AB system,
J2,3¼J6,7¼11.7, 2H, H2, H7 or H3, H6), 6.88 (br d, B part of
AB system, J2,3¼J6,7¼11.7, 2H, H2, H7 or H3, H6), 2.32 (s,
3H, CH3), 2.28 (s, 3H, CH3). 13C NMR (50 MHz, CDCl3):
171.00, 168.95, 168.23, 153.66, 131.92, 122.75, 21.12,
20.81. IR (NaCl film): 3048, 1763, 1591, 1370, 1196,
1171, 1143, 1071, 916, 853. MS (EI, 70 eV) m/z 222 (M+,
0.1), 180 (14), 138 (100), 110 (46), 82 (4), 54 (5). Anal.
Calcd for C11H10O5: C, 59.46; H, 4.54. Found: C, 59.16;
H, 4.64.